Updated:
ICU Medical
ICU Medical is a publicly traded medical device manufacturer, not a family office — founded by Dr. George Lopez in 1984 and listed on Nasdaq as ICUI.
ICU Medical
The record 'ICU Medical Inc/DE' is a corporate filing designation for ICU Medical, a San Clemente, California-based manufacturer of intravenous therapy products, infusion systems, and vascular access devices. The company was founded in 1984 by Dr. George Lopez, who served as CEO for decades before stepping down in 2022. ICU Medical went public in 1992 and trades on the Nasdaq under the ticker ICUI. As an operating company, ICU Medical does not deploy capital as a fund, family office, or institutional allocator. Its investment activity, when it occurs, is corporate M&A — buying businesses to consolidate market share in medical consumables. Notably, in January 2017 ICU Medical acquired Hospira Infusion Systems from Pfizer for approximately $1 billion. In October 2022 it completed the purchase of Smiths Medical's syringe and ambulatory infusion pump business for $1.85 billion (per the firm, October 2022). These are corporate acquisitions, not portfolio allocations. Vivek Jain became CEO in January 2022, succeeding Dr. Lopez. The company has manufacturing and operational sites in the United States, Mexico, Costa Rica, Slovakia, and Italy, reflecting a global supply chain for disposable medical products. ICU Medical employed approximately 15,000 people as of its most recent public filings. The structural reality is that ICU Medical is an industrial operating business with a $2.4 billion market capitalization, not a pool of third-party or family capital. Its governance is public-company standard — a board of directors accountable to diversified shareholders. There is no separate investment committee evaluating external fund commitments, no co-investment posture, and no allocator behavior to observe. Any profile built around this entity as a family office or investor would be a category error.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
—
Country
—
City
—
Corporate office
—
Frequently asked questions
Is ICU Medical a family office or institutional investor?
No. ICU Medical is a publicly traded medical device company listed on Nasdaq under the ticker ICUI. It manufactures infusion pumps, IV sets, and vascular access devices. The entity does not manage external capital, make fund commitments, or operate as a wealth management vehicle. It is an operating business with corporate M&A activity, not a pool of allocable assets.
Why would this name appear in an allocator database?
The filing name 'ICU Medical Inc/DE' likely entered a database through a data vendor that scrapes SEC EDGAR or Delaware corporate records without classifying entity types. Some family office mapping tools ingest all Delaware-registered entities indiscriminately. This is a false positive — a public operating company miscategorized as a potential family office or investment vehicle.
What is ICU Medical's ownership structure?
ICU Medical is widely held by institutional and retail shareholders. Mutual fund complexes including BlackRock and Vanguard are among the largest stockholders, per public 13F filings. There is no single-family control and no identified wealth-origin narrative tied to a family office. Post-founder transition, CEO Vivek Jain leads an independent board-governed enterprise.
Does ICU Medical have any investment activities that resemble a family office?
No. ICU Medical's transactions are corporate M&A designed to expand its product lines and manufacturing footprint. The acquisitions of Hospira Infusion Systems (2017) and Smiths Medical's pump business (2022) were industrial consolidations. The company does not commit to external funds, make direct minority investments, or operate a separate investment arm.
Who controls investment decisions at ICU Medical?
Strategic capital allocation decisions — including M&A, capital expenditure, and share repurchases — are made by CEO Vivek Jain with oversight from ICU Medical's board of directors. There is no CIO, no investment committee allocating to third-party managers, and no family office governance structure. This is standard public-company capital stewardship.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: